Please login to the form below

Not currently logged in

CRF Health

This page shows the latest CRF Health news and features for those working in and with pharma, biotech and healthcare.

eConsent: Busting regulatory myths

eConsent: Busting regulatory myths

By Neetu Pundir, director, Go To Market strategy, CRF Health. One of the major obstacles for researchers when deciding whether to adopt an eConsent approach within their study has been a ... Neetu Pundir is Director of Go To Market Strategy at CRF Health,

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest appointments

  • CRF Health boosts leadership team CRF Health boosts leadership team

    CRF Health, a provider of electronic clinical outcomes assessment (eCOA) solutions for the life sciences industry, has two new additions to the company's executive leadership team. ... In the new position, he will lead CRF Health's overall technology

  • New head at Cardiovascular Research Foundation New head at Cardiovascular Research Foundation

    The Cardiovascular Research Foundation (CRF) has named Jack Lewin as its new president and CEO. ... A second priority will be to examine how the changing economic and scientific environment in healthcare and health research will impact CRF, and then to

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...